Stem cell therapy for COVID-19: Possibilities and challenges.

Area of Science:

• Regenerative Medicine
• Infectious Diseases
• Pulmonology

Background:

• The COVID-19 pandemic has caused millions of cases and significant mortality globally.
• Current treatments for COVID-19 are primarily symptomatic, with no approved vaccines or antiviral drugs.
• Severe respiratory illness affects a substantial portion of COVID-19 patients, often requiring mechanical ventilation and leading to death.

Purpose of the Study:

• To review the potential applications of stem cell therapy in treating critically ill COVID-19 patients.
• To discuss the challenges and possibilities associated with using stem cells for COVID-19 treatment.
• To highlight the growing interest and ongoing clinical trials in stem cell-based therapies for COVID-19.

Main Methods:

• Review of recent studies and clinical trial registrations involving stem cells for COVID-19.
• Analysis of different stem cell sources, dosages, and targeted patient groups in ongoing trials.
• Discussion of the current landscape of stem cell therapy for severe COVID-19.

Main Results:

• Stem cell therapy has been explored in small patient groups in China for severe COVID-19.
• Emergency Use Authorization has been granted for stem cell applications, generating medical community excitement.
• Numerous clinical trials are registered, investigating diverse stem cell approaches for COVID-19 treatment.

Conclusions:

• Stem cell therapy presents a potential alternative therapeutic strategy to reduce mortality in severe COVID-19.
• Further research and clinical trials are crucial to establish the efficacy and safety of stem cells for COVID-19.
• Addressing challenges in stem cell application is essential for successful implementation in COVID-19 patient care.